Rare diseases
Investigational molecules
Locations
Back to Portugal214 clinical trials in Braga, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
PortugalStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
PortugalStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
PortugalA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
PortugalA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
PortugalPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
PortugalRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
PortugalPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
PortugalProphylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)
PortugalA Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
PortugalPhase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations
PortugalEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for multiple sclerosis, including chronic neuropathic pain management and new therapeutic approaches. Research also encompasses frontotemporal dementia and various types of migraines.
Studies focus on both symptom management and disease modification approaches.
Comprehensive research into various skin conditions, including plaque psoriasis, atopic dermatitis, and hidradenitis suppurativa. Clinical trials are evaluating new biological treatments and long-term management strategies.
Focus on developing targeted therapies for chronic skin conditions.
Investigation of novel treatments for autoimmune conditions, including studies on lupus nephritis and immune thrombocytopenia. Research aims to develop more effective therapeutic approaches.
Emphasis on innovative immunological interventions and targeted therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
